NASDAQ:RARE

Ultragenyx Pharmaceutical Stock Insider Trading

etoro logo Buy RARE
*Your capital is at risk
$22.41
+0.630 (+2.89%)
At Close: Jun 03, 2026

Ultragenyx Pharmaceutical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -13.12. In total, the insiders bought 1.31M and sold 169.14K RARE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-13.12
Buy 1.31M shares
Sell 169.14K shares
65% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Apr 16, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Mar 01, 2026
Buy
Common Stock
A-Award
Pinion John Richard
See Remarks
Officer 11 137
Value: $249.6K
Mar 01, 2026
Buy
Common Stock
A-Award
Parschauer Karah Herdman
EVP And Chief Legal Officer
Officer 11 137
Value: $249.6K
Mar 01, 2026
Buy
Common Stock
A-Award
Horn Howard
Chief Financial Officer
C-Suite Officer 6 143
Value: $137.7K
Mar 01, 2026
Buy
Common Stock
A-Award
Crombez Eric
EVP And Chief Medical Officer
Officer 11 643
Value: $260.9K
Mar 01, 2026
Buy
Common Stock
A-Award
Huang Dennis Karl
See Remarks
Officer 11 137
Value: $249.6K
Feb 02, 2026
Sell
Common Stock
S-Sale
Horn Howard
Chief Financial Officer
C-Suite Officer 3 061
Value: $72.1K
Jan 02, 2026
Sell
Common Stock
S-Sale
Horn Howard
Chief Financial Officer
C-Suite Officer 3 150
Value: $71.9K
Dec 29, 2025
Sell
Common Stock
S-Sale
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Officer 85
Value: $3K
Dec 10, 2025
Sell
Common Stock
S-Sale
Horn Howard
Chief Financial Officer
C-Suite Officer 3 081
Value: $112.1K
Oct 13, 2025
Sell
Common Stock
S-Sale
Horn Howard
Chief Financial Officer
C-Suite Officer 7 942
Value: $250.3K
Oct 13, 2025
Sell
Common Stock
S-Sale
Horn Howard
Chief Financial Officer
C-Suite Officer 7 942
Value: $250.3K
Sep 18, 2025
Sell
Common Stock
S-Sale
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Officer 64
Value: $2K
Sep 18, 2025
Sell
Common Stock
S-Sale
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Officer 64
Value: $2K
Sep 12, 2025
Sell
Common Stock
S-Sale
Parschauer Karah Herdman
EVP And Chief Legal Officer
Officer 2 450
Value: $76.4K
Sep 12, 2025
Sell
Common Stock
S-Sale
Parschauer Karah Herdman
EVP And Chief Legal Officer
Officer 2 450
Value: $76.4K
Sep 05, 2025
Sell
Common Stock
S-Sale
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Officer 84
Value: $3K
Sep 05, 2025
Sell
Common Stock
S-Sale
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Officer 84
Value: $3K
Jun 20, 2025
Sell
Common Stock
S-Sale
Sanders Corazon (corsee) D.
Director
Director 2 405
Value: $89.9K
Jun 20, 2025
Sell
Common Stock
S-Sale
Sanders Corazon (corsee) D.
Director
Director 2 405
Value: $89.9K
May 15, 2025
Buy
Common Stock
A-Award
Suliman Shehnaaz
Director
Director 5 740
Value: $200.0K
May 15, 2025
Buy
Stock Option (Right to Buy)
A-Award
Suliman Shehnaaz
Director
Director 10 787
Value: $375.8K
May 15, 2025
Buy
Common Stock
A-Award
Welch Daniel G
Director
Director 5 740
Value: $200.0K
May 15, 2025
Buy
Stock Option (Right to Buy)
A-Award
Welch Daniel G
Director
Director 10 787
Value: $375.8K
May 15, 2025
Buy
Common Stock
A-Award
Sanders Corazon (corsee) D.
Director
Director 5 740
Value: $200.0K
May 15, 2025
Buy
Stock Option (Right to Buy)
A-Award
Sanders Corazon (corsee) D.
Director
Director 10 787
Value: $375.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ULTRAGENYX PHARMACEUTICAL INC.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE